Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia (PREVENT) Cohort: a Multi-center Prospective Cohort Study

NCT06341582 is registered in ClinicalTrials.gov with Guangzhou Women and Children's Medical Center as lead sponsor.

NCT NCT06341582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06341582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia (PREVENT) Cohort: a Multi-center Prospective Cohort Study
Lead sponsor
Guangzhou Women and Children's Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 11, 2023
Completion date
November 30, 2025
Enrollment
2,700 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hemolysis neonatal, neonatal hyperbilirubinemia, neonatal jaundice